Pharmacovigilance: Knowledge, Attitude and Practice among Medical Professionals at a Tertiary Care Hospital in Nepal
Introduction: Awareness regarding pharmacovigilance and adverse drug reaction reporting by medical professionals significantly contribute to the safer use of medicine. Therefore, the objective of this study was to assess the knowledge, attitude, and practices regarding pharmacovigilance among the medical professionals at a tertiary care hospital in Nepal. Methods: This study was a descriptive cross-sectional study conducted at Lumbini Medical College and Teaching Hospital. Printed questionnaires were distributed to all the medical professionals and collected data were analyzed to find the knowledge, attitude, and practices of the medical professionals regarding pharmacovigilance. Results: A total of 107 medical professionals, 77 (71.96%) males and 30 (28.04%) females, participated in the study. The overall response rate was 98.16%. In this study,70.1% of medical professionals knew the definition of pharmacovigilance, and more than half of the participants(63.6%) did not know the existence of the national pharmacovigilance center. Regarding attitude, 52.3% of the medical professionals strongly agreed that adverse drug reaction reporting and monitoring systems were beneficial to patients or improved patient care. Half of the medical professionals would sometimes counsel the patients about adverse drug reactions. Almost half of medical professionals mentioned that the major factor behind underreporting was insufficient knowledge of where to report adverse drug reactions. Training on pharmacovigilance was the main recommendation from the participants (52.3%) to improve the pharmacovigilance program. Conclusion: There is room for improvement in the knowledge, attitude and practice of the participants. Most medical professionals suggested training or continuing medical education as a way to improve pharmacovigilance programs.
Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health Professionals’ Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis. PloS One. 2016;11(3):e0152221.PMID: 27010447 DOI: https://doi.org/10.1371/journal.pone.0152221
Srinivasan V, SheelaD, Mridula D. Knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a tertiary care hospital- A questionnaire study. Biomedical and Pharmacology Journal. 2017;10(3):1441-47. DOI: https://dx.doi.org/10.13005/bpj/1251
Paveliu MS, Bengea-Luculescu S, TomaM,Paveliu SF. Perception on adverse drug reaction reporting by physicians working in southern Romania. Maedica (Bucur). 2013;8(1):17-25.PMID: 24023593 PMCID: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc3749755/
Katekhaye VM, Kadhe NG, John J,Pawar SR. Knowledge, attitude and practice of pharmacovigilance among medical professionals at a tertiary care hospital in Mumbai, Maharashtra, India. International Journal of Research in Medical Sciences. 2017;5(1):156-61. DOI:https://dx.doi.org/10.18203/2320-6012.ijrms20164540
KC S, Tragulpiankit P, Gorsanan, Edwards IR. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol Toxicol. 2013;14(0):16. PMID: 23497690 DOI: https://doi.org/10.1186/2050-6511-14-16
Bista N. Pharmacovigilance in Nepal [Internet]. Nepal: Pharma Info Nepal, 2020.[Accessed on 23rd September, 2021]Available from: https://pharmainfonepal.com/pharmacovigilance-in-nepal/
KC S, Tragulpiankit, Edwards IRP, Gorsanan S. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal. Int J Risk Saf Med. 2013;25(1):1-16. PMID: 23442293 DOI: https://doi.org/10.3233/jrs-120578
Bhavana A, Sekhar DG, Rekha M, Gopinath C. Reasons for underreporting adverse drug reactions: A review. Journal of Pharmacovigilance.2014;2(5):128. Available from: https://www.longdom.org/conference-abstracts-files/2329-6887.S1.014-021.pdf
Palaian S, Ibrahim MI, Mishra P. Health professionalsˈ knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharmacy Pract (Granada). 2011;9(4):228-35. PMID: 24198861 DOI: https://doi.org/10.4321/s1886-36552011000400008
Kunnoor NS, Singanal S,Lohit K. Perception of doctors towards Adverse Drug Reaction (ADR) reporting: A cross sectional survey using a validated questionnaire. International Journal of Basic&Clinical Pharmacology. 2017;6(11):2671-5. DOI:https://dx.doi.org/10.18203/2319-2003.ijbcp20174786
Shroukh WA, Shakhatreh FM, YaseinNA,Sharkas GF. A survey on the knowledge, attitudes and practices of physicians towards pharmacovigilance in Jordanian health centres. Int Health. 2018;10(5):363-70. PMID: 29718320 DOI: https://doi.org/10.1093/inthealth/ihy029
Alshammari TM, Almoslem MJ. Knowledge, attitudes & practices of healthcare professionals in hospital towards the reporting of adverse drug reaction in Saudi Arabia: A multi centre cross sectional study. Saudi Pharma J. 2018;26(7):925-31. PMID: 30416347 DOI: https://doi.org/10.1016/j.jsps.2018.04.012
Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi pharm J. 2017;25(6):830-37.PMID: 28951666 DOI: https://doi.org/10.1016/j.jsps.2016.12.004
Gupta P,Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors. Journal of Pharmaceutical Science and Research. 2011;3(2):1064-69. Available from: https://www.jpsr.pharmainfo.in/Documents/Volumes/Vol3Issue02/jpsr%2003110205.pdf
Gupta SK, Nayak RP, Shivaranjani R,Vidyarthi SK. A questionnaire study on the knowledge, attitude and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45-52. PMID: 25657902 DOI: https://doi.org/10.4103/2229-3485.148816
Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9(0):14.PMID: 19671176 DOI: https://doi.org/10.1186/1472-6904-9-14
Ekman E, Bȁckstrőm M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J ClinPharmacol. 2009;65(1):43-6.PMID: 18825377 DOI: https://doi.org/10.1007/s00228-008-0564-9
Das L, Bhattacharjee P, Ghosh R, Das UK, Ray T. Knowledge, attitude and practice of pharmacovigilance among doctors in a tertiary care teaching hospital of Tripura. Nationall Journal of Physiology, Pharmacy and Pharmacology. 2017;7(2):218-23. https://www.researchgate.net/publication/311997199
Mishra PS,Gudsurkar G. Cross sectional study to assess the awareness of pharmacovigilance among post graduate residents of tertiary care medical college hospital of central India.International Journal of Basic&Clinical Pharmacology. 2018;7(3):386-90. DOI:https://dx.doi.org/10.18203/2319-2003.ijbcp20180501
Copyright (c) 2021 Kamal Kandel
This work is licensed under a Creative Commons Attribution 4.0 International License.
- The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- JLMC requires an exclusive licence to publish the article first in its journal in print and online.
- The corresponding author should read and agree to the following statement before submission of the manuscript for publication,
- License agreement
- In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
- I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.
Please visit Creative Commons web page for details of the terms.